UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Genexine to start P1 trial of Covid-19 treatment in US
Genexine said NeoImmuneTech, its U.S. affiliate, has received approval from...
by Lee Han-soo
|
2020-06-11 16:26
라인
Greater Seoul remains hot spot of Covid-19 infections
Korea’s new virus cases are concentrating in the Seoul metro region, as clu...
by Lee Han-soo
|
2020-06-11 12:08
라인
'Imfinzi changed treatment paradigm for non-resectable NSCLC'
Clinical results have shown that AstraZeneca's Imfinzi may be an effect...
by Lee Han-soo
|
2020-06-10 17:58
라인
Myongji Hospital to develop AI-based Covid-19 detection kit in 3-way project
Myongji Hospital said Wednesday that it would develop a mobile artificial i...
by Lee Han-soo
|
2020-06-10 16:07
라인
New virus cases rise back amid unrelenting cluster infections in greater Seoul
Korea's new Covid-19 cases spiked back as sporadic cluster infections c...
by Lee Han-soo
|
2020-06-10 11:49
라인
Baekje to distribute Leo Pharma's dermatology products
Baekje Pharmaceutical said that it would exclusively distribute all of Leo ...
by Lee Han-soo
|
2020-06-09 16:49
라인
LegoChem licenses in Covid-19 treatment candidates
LegoChem BioScience licensed in two Covid-19 treatment candidates from the ...
by Lee Han-soo
|
2020-06-09 16:48
라인
Researchers find recurrence cause for pemphigus
A research team at Gangnam Severance Hospital has revealed the recurrence c...
by Lee Han-soo
|
2020-06-09 13:37
라인
Korean, US firms in legal battle over Covid-19 vaccine know-how
A legal dispute is underway between American vaccine maker Inovio and VGXI,...
by Lee Han-soo
|
2020-06-08 21:28
라인
[Reporter's Notebook] Korean firms found something missing in ‘virtual’ ASCO 2020
The 2020 American Society of Clinical Oncology (ASCO) Annual Meeting comple...
by Lee Han-soo
|
2020-06-08 16:54
라인
Environmental chemicals causing chronic kidney disease identified
Researchers at Seoul National University Boramae Hospital have identified e...
by Lee Han-soo
|
2020-06-08 15:14
라인
IVI ties up with SNUH for clinical trial of Covid-19 vaccine
The International Vaccine Institute (IVI) and Seoul National University Hos...
by Lee Han-soo
|
2020-06-04 17:04
라인
[ASCO 2020 ⑤] Lunit opens possibility of personalized cancer treatment with AI platform
Lunit has become Korea’s only AI-based medical image analytics company to p...
by Lee Han-soo
|
2020-06-04 16:25
라인
MedPacto to test Vactosertib for treating NSCLC
MedPacto has applied for phase 2 clinical trials concerning the combined us...
by Lee Han-soo
|
2020-06-04 12:43
라인
Dupixent to provide new treatment options for asthma patients
Sanofi-Aventis Korea said Wednesday it would enter the local asthma drug ma...
by Lee Han-soo
|
2020-06-03 17:54
라인
New plasma-based method found to treat refractory blood cancer
A new method has been found to treat chronic myelogenous leukemia, a type o...
by Lee Han-soo
|
2020-06-03 16:29
라인
Treating helicobacter bacteria after gastric cancer surgery lifts survival rate
A research team at Seoul National University Bundang Hospital has discovere...
by Lee Han-soo
|
2020-06-03 16:05
라인
CDK 4/6 inhibitor market to heat up on insurance benefits
Hormone receptor (HR) positive, human epidermal growth factor receptor 2 (H...
by Lee Han-soo
|
2020-06-02 17:13
라인
[ASCO 2020 ②] GC confirms safety, efficacy of anti-EGFR monoclonal antibody
GC has come up with optimal interim results for its phase 1b/2a clinical tr...
by Lee Han-soo
|
2020-06-02 11:20
라인
[ASCO 2020 ①] Samsung Bioepis’ anticancer biosimilar shows equal quality to original drug
Samsung Bioepis headquarters in Songdo, Incheon. Samsung Bioepis said tha...
by Lee Han-soo
|
2020-06-01 16:14
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top